CLINACIN 25 MG ANTIBIOTIC TABLETS FOR DOGS AND CATS

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE

제공처:

CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED

INN (International Name):

clindamycin as HCl(25mg/Tb)

약제 형태:

ORAL TABLET

구성:

CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE ANTIBIOTIC Active 25.0 mg/Tb

패키지 단위:

100 Tabs

수업:

VM - Veterinary Medicine

Manufactured by:

CHANELLE PHARMACEUTI

치료 그룹:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

치료 영역:

ANTIBIOTIC & RELATED

치료 징후:

ACTINOMYCES SPP. | BACTEROIDES SPP. | CLOSTRIDIUM SPP. | DENTAL INFECTION | FUSOBACTERIUM SPP. | OSTEOMYELITIS | PEPTOSTREPTOCOCCUS SPP. | PROPIONIBACTERIUM SPP. | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS SPP. | WOUND INFECTIONS | ABSCESSES | ANAEROBIC BACTERIA | CLOSTRIDIUM BOTULINUM | CLOSTRIDIUM CHAUVOEI | CLOSTRIDIUM FALLAX | CLOSTRIDIUM FESERI | CLOSTRIDIUM HEMOLYTICUM | CLOSTRIDIUM NOVYI | CLOSTRIDIUM PERFRINGENS TYPES | CLOSTRIDIUM SEPTICUM | CLOSTRIDIUM SORDELLI | CLOSTRIDIUM SPOROGENES | CLOSTRIDIUM TETANI | INCLUDING B-LACTAMASE PRODUCIN | STAPHYLOCOCCOSIS

제품 요약:

Poison schedule: 4; Withholding period: WHP: N/A.; Host/pest details: CAT: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; For the treatment of infected wounds, abscesses and dental infections in dogs and cats and osteomyelitis in dogs where these infections are caused by bacteria susceptible to clindamycin.DO NOT USE in food producing species of animals or horses. This product is contraindicated for use in rabbits, hamsters, guinea pigs and in animals with a history of hypersensitivity to clindamycin or lincomycin.

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

LABEL IMAGE PROUDLY SUPPLIED BY
[e-mail]

제품 특성 요약

PRODUCT NAME: CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
clindamycin is an antibiotic ingredient.
TRADE NAME:
CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
PRODUCT CODE:
18934, 18935 and 18936
RECOMMENDED USE:
Antibiotic for treatment of dogs and cats (prescription animal
remedy).
APVMA NO:
57882, 57884, 57885
CREATION DATE:
June, 2007
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25, S45. Do not breathe dust. Avoid contact with eyes. In case
of accident or if you feel
unwell, contact a doctor or Poisons Information Centre immediately
(show this MSDS where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A round or oblong white tablet with a breakline on one side.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. The
active ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product as it
may cause sensitisation.
Adverse reactions associated with clindamycin treatment include:
diarrhoea, pseudomembranous colitis, nausea,
vomiting, abdominal pain/cramps, rash, and/or itch.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSU